Tamil Nadu Petro Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:25 pm

Quick Insight

Tamil Nadu Petro Products Ltd, with a share price of 102 and a market cap of 914 Cr., exhibits a moderate P/E ratio of 12.8, reflecting investor confidence. However, the lower ROE and ROCE at 5.04% and 6.89% respectively suggest room for improvement in capital utilization efficiency. The OPM stands at 10%, indicating decent operational performance. With reserves at 822 Cr. and borrowings of ₹135 Cr., the company maintains a healthy financial position. A low P/BV ratio of 0.68x may indicate undervaluation, while a comfortable ICR of 14.63x signifies strong debt-servicing ability. Overall, focusing on enhancing return ratios could drive long-term shareholder value for Tamil Nadu Petro Products Ltd.

Competitors of Tamil Nadu Petro Products Ltd

All Competitor Stocks of Tamil Nadu Petro Products Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:40 am

Below is a detailed analysis of the quarterly data for Tamil Nadu Petro Products Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 463.00 Cr.. The value appears strong and on an upward trend. It has increased from 455.00 Cr. (Mar 2025) to 463.00 Cr., marking an increase of 8.00 Cr..
• For Expenses, as of Jun 2025, the value is 416.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 429.00 Cr. (Mar 2025) to 416.00 Cr., marking a decrease of 13.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2025) to 10.00%, marking an increase of 4.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 11.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.92. The value appears strong and on an upward trend. It has increased from 2.99 (Mar 2025) to 3.92, marking an increase of 0.93.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:05 am

Growth

Last Updated: September 5, 2025, 1:41 pm

Balance Sheet

Last Updated: May 13, 2025, 2:37 pm

Below is a detailed analysis of the balance sheet data for Tamil Nadu Petro Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 90.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 90.00 Cr..
• For Reserves, as of Mar 2025, the value is 822.00 Cr.. The value appears strong and on an upward trend. It has increased from 769.00 Cr. (Mar 2024) to 822.00 Cr., marking an increase of 53.00 Cr..
• For Borrowings, as of Mar 2025, the value is 135.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 18.00 Cr. (Mar 2024) to 135.00 Cr., marking an increase of 117.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 307.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 213.00 Cr. (Mar 2024) to 307.00 Cr., marking an increase of 94.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,354.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,091.00 Cr. (Mar 2024) to 1,354.00 Cr., marking an increase of 263.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 285.00 Cr.. The value appears to be declining and may need further review. It has decreased from 304.00 Cr. (Mar 2024) to 285.00 Cr., marking a decrease of 19.00 Cr..
• For CWIP, as of Mar 2025, the value is 452.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2024) to 452.00 Cr., marking an increase of 403.00 Cr..
• For Investments, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Other Assets, as of Mar 2025, the value is 602.00 Cr.. The value appears to be declining and may need further review. It has decreased from 722.00 Cr. (Mar 2024) to 602.00 Cr., marking a decrease of 120.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,354.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,091.00 Cr. (Mar 2024) to 1,354.00 Cr., marking an increase of 263.00 Cr..

Notably, the Reserves (822.00 Cr.) exceed the Borrowings (135.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Tamil Nadu Petro Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.49. This value is within the healthy range. It has increased from 5.56 (Mar 24) to 6.49, marking an increase of 0.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.49. This value is within the healthy range. It has increased from 5.56 (Mar 24) to 6.49, marking an increase of 0.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.29. This value is within the healthy range. It has increased from 8.08 (Mar 24) to 9.29, marking an increase of 1.21.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 101.35. It has increased from 95.53 (Mar 24) to 101.35, marking an increase of 5.82.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 101.35. It has increased from 95.53 (Mar 24) to 101.35, marking an increase of 5.82.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 203.04. It has increased from 185.46 (Mar 24) to 203.04, marking an increase of 17.58.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 10.18. This value is within the healthy range. It has decreased from 12.08 (Mar 24) to 10.18, marking a decrease of 1.90.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.37. This value is within the healthy range. It has decreased from 9.56 (Mar 24) to 7.37, marking a decrease of 2.19.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.73. This value is within the healthy range. It has increased from 7.21 (Mar 24) to 8.73, marking an increase of 1.52.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.49. This value is within the healthy range. It has increased from 5.56 (Mar 24) to 6.49, marking an increase of 0.93.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.49. This value is within the healthy range. It has increased from 5.56 (Mar 24) to 6.49, marking an increase of 0.93.
• For PBDIT Margin (%), as of Mar 25, the value is 5.01. This value is below the healthy minimum of 10. It has decreased from 6.51 (Mar 24) to 5.01, marking a decrease of 1.50.
• For PBIT Margin (%), as of Mar 25, the value is 3.63. This value is below the healthy minimum of 10. It has decreased from 5.15 (Mar 24) to 3.63, marking a decrease of 1.52.
• For PBT Margin (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 10. It has increased from 3.88 (Mar 24) to 4.30, marking an increase of 0.42.
• For Net Profit Margin (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 3.00 (Mar 24) to 3.19, marking an increase of 0.19.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 8. It has increased from 3.00 (Mar 24) to 3.19, marking an increase of 0.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 15. It has increased from 5.82 (Mar 24) to 6.39, marking an increase of 0.57.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.00. This value is below the healthy minimum of 10. It has decreased from 9.13 (Mar 24) to 6.00, marking a decrease of 3.13.
• For Return On Assets (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has decreased from 4.59 (Mar 24) to 4.30, marking a decrease of 0.29.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.12, marking an increase of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.13. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.13, marking an increase of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.49. It has decreased from 1.52 (Mar 24) to 1.49, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 2.35. This value is within the healthy range. It has decreased from 4.59 (Mar 24) to 2.35, marking a decrease of 2.24.
• For Quick Ratio (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.76 (Mar 24) to 1.94, marking a decrease of 1.82.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.63. This value exceeds the healthy maximum of 8. It has increased from 6.57 (Mar 24) to 9.63, marking an increase of 3.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 26.95 (Mar 24) to 0.00, marking a decrease of 26.95.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 18.56 (Mar 24) to 0.00, marking a decrease of 18.56.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 73.05 (Mar 24) to 0.00, marking a decrease of 73.05.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 81.44 (Mar 24) to 0.00, marking a decrease of 81.44.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.63. This value is within the healthy range. It has decreased from 15.13 (Mar 24) to 14.63, marking a decrease of 0.50.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.37. This value is within the healthy range. It has decreased from 9.93 (Mar 24) to 7.37, marking a decrease of 2.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 375.08. It has increased from 283.75 (Mar 24) to 375.08, marking an increase of 91.33.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.20, marking an increase of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 4.10. This value is below the healthy minimum of 5. It has increased from 2.61 (Mar 24) to 4.10, marking an increase of 1.49.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.33, marking a decrease of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 73.04 (Mar 24) to 0.00, marking a decrease of 73.04.
• For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 0.81 (Mar 24) to 0.68, marking a decrease of 0.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.33, marking a decrease of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.09, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness